Ratings by H.C. Wainwright
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Joseph Pantginis | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
9.00 (N/A) |
|
Details | |
| 3/6/2026 | Joseph Pantginis | aTyr Pharma | ATYR | Maintain | Neutral (N/A) |
N/A (N/A) |
|
Details | |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 7,541 more... | |||||||||


